The Federal Court has ordered pharmaceutical giant Johnson & Johnson to pay almost $2.6 million in damages to three women implanted with faulty pelvic mesh implants.

Key points: A class action involving more than 1,350 women successfully sued Johnson & Johnson last year

A class action involving more than 1,350 women successfully sued Johnson & Johnson last year Hundreds of women have suffered serious and debilitating side effects from the company's pelvic mesh implants

Hundreds of women have suffered serious and debilitating side effects from the company's pelvic mesh implants The court is yet to make full orders in the case

The mesh devices have left hundreds of Australian women with serious side effects including chronic pain, infections, and the inability to have sex.

Last November the Federal Court ruled in favour of the three lead applicants in a class action of more than 1,350 women who sued Johnson & Johnson and two subsidiaries, including Ethicon.

The court found Johnson & Johnson were "negligent", driven by commercial interests, and failed to give appropriate or sufficient remedial action once it knew of problems with the implants.

The three women awarded damages, Kathryn Gill, Diane Dawson and Ann Sanders, were not in court on Tuesday but about a dozen women who were party to the class action were present as the order was made.

Some who said they were left in excruciating pain from the faulty products stood at times, while others walked into court with walking aids.

The court had previously heard there could be thousands more women who are not yet aware they have the faulty device in their bodies.

Shine Lawyers, who brought the class action, said the number of women coming forward was still rising in what it described as the largest women's health class action in Australia's history.

The pelvic mesh, also known as transvaginal mesh, was implanted into the pelvis for a variety of conditions, usually pelvis organ prolapse and stress urinary incontinence.

The devices were banned in 2017 and a senate inquiry in 2018 found women were "ignored and treated appallingly".

Federal Court Justice Anna Katzmann last year said the evidence in the case was "overwhelming" and the devices were not tested properly.

It was also found that the companies responsible knew they did not have sufficient data to show the implants were safe.

During the trial, the court heard of a "tidal wave" of aggressive marketing to surgeons and patients that suggested implanting the mesh was a "quick and easy operation".

Calls for other devices to be banned

At Tuesday's ruling, there was further discussion about whether Johnson & Johnson breached their duty of care in Australia for failing to provide adequate warning about the risks of its products.

An advocate for mesh implant sufferers Rachael Wise told the ABC outside court women "need help now".

"In my opinion, myself and other women have been placated, ignored and this needs to be immediately addressed by the Government," she said.

Advocates for implant sufferers (L-R) Helen Geyer-Jackson, Rachael Wise, Francene Henderson, Robyn Ramster and Trish Sara at court. ( ABC News: Liv Casben )

"Mostly we just want to get better. We just want good health care."

Ms Wise urged any women who have had surgery for pelvic organ prolapse or incontinence need to contact Shine Lawyers before April 9 to register for the class action.

"Even if you don't think anything's wrong still ring Shine and register ... if you're not in this you won't get anything."

She said mesh implants have impacted women as far back as 1996 and Tuesday's order for damages was "validation".

"The complications are so far reaching that it's really hard to articulate, even to your own family.

"People just don't understand how much it impacts your life.

"It's affected our womanhood, our relationships with our partners, our time with our children and our families ... (the ability) for some people to work."

The Australian Pelvic Mesh Support Group continue to campaign for the Therapeutic Goods Administration (TGA) to remove all Johnson & Johnson mesh devices from the market effective immediately.

These include meshes implanted via the abdomen.

Johnson & Johnson has not said whether it will appeal the judgment or the payout.

The court is yet to make full orders in the case.

In a statement, Johnson & Johnson subsidiary Ethicon said it "empathises" with the women who experienced complications but believe it acted "ethically and responsibly" in research, development and supply of the implants.

"Pelvic mesh has helped improve the quality of life for millions of women with pelvic organ prolapse and stress urinary incontinence, which are serious, debilitating conditions that can cause daily suffering," the statement read.

"Ethicon supports and encourages informed treatment decisions made by patients in consultation with doctors on the benefits and risks of surgical procedures to treat these debilitating conditions."